204 related articles for article (PubMed ID: 28337871)
1. Cytokine modulation in patients with idiopathic pulmonary fibrosis undergoing treatment with steroids, immunosuppressants, and IFN-γ 1b.
Marinari S; De Iuliis V; Dadorante V; Colella S; Marino A; Nunziata A; Flati V; Caruso M; Pennelli A; De Benedetto F; Matera S; Capodifoglio S; Martinotti S; Caputi S; Toniato E
J Biol Regul Homeost Agents; 2017; 31(1):59-69. PubMed ID: 28337871
[TBL] [Abstract][Full Text] [Related]
2. Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).
Antoniou KM; Alexandrakis MG; Sfiridaki K; Tsiligianni I; Perisinakis K; Tzortzaki EG; Siafakas NM; Bouros DE
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):105-10. PubMed ID: 15281431
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
[TBL] [Abstract][Full Text] [Related]
4. Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosis.
Luppi F; Losi M; D'Amico R; Fabbri LM; Richeldi L
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):64-8. PubMed ID: 19960790
[TBL] [Abstract][Full Text] [Related]
5. Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients.
Antoniou KM; Tzanakis N; Tzortzaki EG; Malagari K; Koutsopoulos AV; Alexandrakis M; Wells AU; Siafakas NM
Pulm Pharmacol Ther; 2008 Dec; 21(6):840-4. PubMed ID: 18644457
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
7. Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis.
Diaz KT; Skaria S; Harris K; Solomita M; Lau S; Bauer K; Smaldone GC; Condos R
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):79-87. PubMed ID: 22360317
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro.
Cu A; Ye Q; Sarria R; Nakamura S; Guzman J; Costabel U
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):147-54. PubMed ID: 20560295
[TBL] [Abstract][Full Text] [Related]
9. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
Yamagata A; Arita M; Tachibana H; Tokioka F; Sugimoto C; Sumikawa H; Tanaka T; Yasui H; Fujisawa T; Nakamura Y; Suda T; Ishida T
Respir Res; 2021 Apr; 22(1):115. PubMed ID: 33879137
[TBL] [Abstract][Full Text] [Related]
10. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis.
Furuie H; Yamasaki H; Suga M; Ando M
Eur Respir J; 1997 Apr; 10(4):787-94. PubMed ID: 9150314
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation.
Lee J; Arisi I; Puxeddu E; Mramba LK; Amicosante M; Swaisgood CM; Pallante M; Brantly ML; Sköld CM; Saltini C
PLoS One; 2018; 13(4):e0194803. PubMed ID: 29649237
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis.
Strieter RM; Starko KM; Enelow RI; Noth I; Valentine VG;
Am J Respir Crit Care Med; 2004 Jul; 170(2):133-40. PubMed ID: 15044205
[TBL] [Abstract][Full Text] [Related]
13. Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b.
Antoniou KM; Tzortzaki EG; Alexandrakis MG; Zervou M; Tzanakis N; Sfiridaki K; Bouros DE; Siafakas NM
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):204-9. PubMed ID: 16315783
[TBL] [Abstract][Full Text] [Related]
14. Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF).
Skaria SD; Yang J; Condos R; Smaldone GC
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):37-42. PubMed ID: 26237354
[TBL] [Abstract][Full Text] [Related]
15. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.
Kotsianidis I; Nakou E; Bouchliou I; Tzouvelekis A; Spanoudakis E; Steiropoulos P; Sotiriou I; Aidinis V; Margaritis D; Tsatalas C; Bouros D
Am J Respir Crit Care Med; 2009 Jun; 179(12):1121-30. PubMed ID: 19342412
[TBL] [Abstract][Full Text] [Related]
16. Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis.
Borie R; Quesnel C; Phin S; Debray MP; Marchal-Somme J; Tiev K; Bonay M; Fabre A; Soler P; Dehoux M; Crestani B
PLoS One; 2013; 8(1):e53736. PubMed ID: 23341987
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
[TBL] [Abstract][Full Text] [Related]
18. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.
Le TT; Karmouty-Quintana H; Melicoff E; Le TT; Weng T; Chen NY; Pedroza M; Zhou Y; Davies J; Philip K; Molina J; Luo F; George AT; Garcia-Morales LJ; Bunge RR; Bruckner BA; Loebe M; Seethamraju H; Agarwal SK; Blackburn MR
J Immunol; 2014 Oct; 193(7):3755-68. PubMed ID: 25172494
[TBL] [Abstract][Full Text] [Related]
19. Treating IPF--all or nothing? A PRO-CON debate.
Behr J; Kolb M; Cox G
Respirology; 2009 Nov; 14(8):1072-81. PubMed ID: 19909457
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
Wuyts WA; Willems S; Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Rinaldi M; Vanhooren HM; Geudens N; Verleden SE; Demedts MG; Thomeer M; Verbeken EK; Verleden GM
Exp Lung Res; 2010 Dec; 36(10):602-14. PubMed ID: 20874225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
